Pfizer Signs Up Seven New York Institutions To Create Biomedical Discovery Engine

Pfizer doesn't exactly do things by halves. Two years after pulling off the sector's biggest merger, it now appears to be carrying out the largest-scale – and most ambitious – academic tie-up yet.